These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 16240215)
1. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report. Agrawal A; Tutuian R; Hila A; Castell DO Dig Dis Sci; 2005 Nov; 50(11):2059-62. PubMed ID: 16240215 [No Abstract] [Full Text] [Related]
3. How new drugs help treat erectile dysfunction. Weeks B; Ficorelli CT Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991 [No Abstract] [Full Text] [Related]
4. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction. Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809 [TBL] [Abstract][Full Text] [Related]
5. Failure of PDE5 inhibitor use: a case of nonresponder? (CME). Chung E J Sex Med; 2010 Apr; 7(4 Pt 1):1321-3. PubMed ID: 20492423 [No Abstract] [Full Text] [Related]
7. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression. Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379 [TBL] [Abstract][Full Text] [Related]
8. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. Jannini EA; Isidori AM; Gravina GL; Aversa A; Balercia G; Bocchio M; Boscaro M; Carani C; Corona G; Fabbri A; Foresta C; Forti G; Francavilla S; Granata AR; Maggi M; Mansani R; Palego P; Spera G; Vetri M; Lenzi A; J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039 [TBL] [Abstract][Full Text] [Related]
9. There have been inadequate warnings that erectile dysfunction drugs can cause blindness. Wolfe SM MedGenMed; 2005 Dec; 7(4):61. PubMed ID: 16614683 [No Abstract] [Full Text] [Related]
12. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction. Mason RG J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189 [No Abstract] [Full Text] [Related]
13. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications. Agarwal P; Sander GE; Giles TD Am J Geriatr Cardiol; 2004; 13(6):332-5. PubMed ID: 15538074 [No Abstract] [Full Text] [Related]
14. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417 [TBL] [Abstract][Full Text] [Related]
15. Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'. Perimenis P Expert Opin Pharmacother; 2005 Jan; 6(1):1-2. PubMed ID: 15709877 [No Abstract] [Full Text] [Related]
16. [Birthday of a "potency pill". Helmut Newton celebrates posthumously likewise]. Keil TU MMW Fortschr Med; 2004 Jul; 146(29-30):61. PubMed ID: 15540567 [No Abstract] [Full Text] [Related]
17. Towards optimal ED management: educational forum - II. Brock G Can J Urol; 2001 Dec; 8(6):1419-20. PubMed ID: 11799971 [No Abstract] [Full Text] [Related]
18. Therapy of ED: PDE-5 Inhibitors. Shabsigh R Endocrine; 2004; 23(2-3):135-41. PubMed ID: 15146092 [TBL] [Abstract][Full Text] [Related]
20. Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active. Harv Health Lett; 2014 May; 39(7):7. PubMed ID: 25073193 [No Abstract] [Full Text] [Related] [Next] [New Search]